Akamai Technologies, Inc. (NasdaqGS:AKAM) is talking to Morgan Stanley (NYSE:MS) about strategic alternatives, including a potential sale of the $11.5 billion firm, according to a report from Bloomberg, citing unnamed people familiar with the matter. Akamai did not immediately respond to a request for comment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107 USD | +0.70% | +3.38% | +14.70% |
04:32am | Ardent Health prices US IPO below target range to raise $192 mln | RE |
17/07 | Hedge funds shed risk in tech megacap sell-off, Goldman says | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.70% | 17TCr | |
+30.18% | 17TCr | |
+31.43% | 13TCr | |
-7.27% | 12TCr | |
-7.46% | 3.55TCr | |
+1.67% | 2.35TCr | |
+54.24% | 1.88TCr | |
-0.67% | 1.69TCr | |
-21.01% | 1.78TCr | |
+4.91% | 1.56TCr |
- Stock Market
- Equities
- MS Stock
- News Morgan Stanley
- Akamai Reportedly Considers Strategic Options, Including Company Sale